Literature DB >> 16240349

Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD.

Christoph Münch1, Angela Rosenbohm, Anne-Dorte Sperfeld, Ingo Uttner, Sven Reske, Bernd J Krause, Reinhard Sedlmeier, Thomas Meyer, Clemens O Hanemann, Gabriele Stumm, Albert C Ludolph.   

Abstract

A heterozygous R1101K mutation of the p150 subunit of dynactin (DCTN1) is reported in a family with amyotrophic lateral sclerosis (ALS) and co-occurrence of frontotemporal dementia (FTD). Two members of our kindred were affected with motor neuron disease and two with dementia in an autosomal dominant pattern of inheritance. We excluded the involvement of the ALS and FTD-linked genes for copper/zinc superoxide dismutase (SOD1) and tau. The R1101K sequence alteration of the DCTN1 gene may predispose subjects to ALS and FTD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16240349     DOI: 10.1002/ana.20631

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  69 in total

1.  Effects of diet on synaptic vesicle release in dynactin complex mutants: a mechanism for improved vitality during motor disease.

Authors:  Joel M Rawson; Tabita Kreko; Holly Davison; Rebekah Mahoney; Alex Bokov; Leo Chang; Jon Gelfond; Greg T Macleod; Benjamin A Eaton
Journal:  Aging Cell       Date:  2012-02-22       Impact factor: 9.304

Review 2.  TAR DNA-binding protein 43 in neurodegenerative disease.

Authors:  Alice S Chen-Plotkin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurol       Date:  2010-03-16       Impact factor: 42.937

Review 3.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

Review 4.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

5.  Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy.

Authors:  Rosa Capozzo; Celeste Sassi; Monia B Hammer; Simona Arcuti; Chiara Zecca; Maria R Barulli; Rosanna Tortelli; J Raphael Gibbs; Cynthia Crews; Davide Seripa; Francesco Carnicella; Claudia Dell'Aquila; Marco Rossi; Filippo Tamma; Francesco Valluzzi; Bruno Brancasi; Francesco Panza; Andrew B Singleton; Giancarlo Logroscino
Journal:  Alzheimers Dement       Date:  2017-03-03       Impact factor: 21.566

Review 6.  Aggresome formation and neurodegenerative diseases: therapeutic implications.

Authors:  J A Olzmann; L Li; L S Chin
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

7.  Regulation of dynactin through the differential expression of p150Glued isoforms.

Authors:  Ram Dixit; Jennifer R Levy; Mariko Tokito; Lee A Ligon; Erika L F Holzbaur
Journal:  J Biol Chem       Date:  2008-09-22       Impact factor: 5.157

Review 8.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

9.  CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila.

Authors:  Biljana Ermanoska; William W Motley; Ricardo Leitão-Gonçalves; Bob Asselbergh; LaTasha H Lee; Peter De Rijk; Kristel Sleegers; Tinne Ooms; Tanja A Godenschwege; Vincent Timmerman; Kenneth H Fischbeck; Albena Jordanova
Journal:  Neurobiol Dis       Date:  2014-05-05       Impact factor: 5.996

Review 10.  ER stress and unfolded protein response in amyotrophic lateral sclerosis.

Authors:  Kohsuke Kanekura; Hiroaki Suzuki; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2009-01-30       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.